MannKind Corporation (MNKD)
NASDAQ: MNKD · Real-Time Price · USD
5.74
-0.09 (-1.54%)
Feb 11, 2026, 4:00 PM EST - Market closed

MannKind Revenue

MannKind had revenue of $82.13M in the quarter ending September 30, 2025, with 17.20% growth. This brings the company's revenue in the last twelve months to $313.79M, up 17.44% year-over-year. In the year 2024, MannKind had annual revenue of $285.50M with 43.50% growth.

Revenue (ttm)
$313.79M
Revenue Growth
+17.44%
P/S Ratio
5.46
Revenue / Employee
$770,975
Employees
407
Market Cap
1.76B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024285.50M86.54M43.50%
Dec 31, 2023198.96M99.19M99.42%
Dec 31, 202299.77M24.33M32.25%
Dec 31, 202175.44M10.30M15.81%
Dec 31, 202065.14M2.11M3.34%
Dec 31, 201963.04M35.18M126.28%
Dec 31, 201827.86M16.11M137.20%
Dec 31, 201711.75M-163.01M-93.28%
Dec 31, 2016174.76M--
Dec 31, 2015---
Dec 31, 2014---
Dec 31, 2013---
Dec 31, 2012---
Dec 31, 2011---
Dec 31, 2010---
Dec 31, 2009---
Dec 31, 2008---
Dec 31, 2007---
Dec 31, 2006---
Dec 31, 2005---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Ardelyx398.23M
Vericel258.72M
Stoke Therapeutics205.63M
Syndax Pharmaceuticals111.30M
Nurix Therapeutics83.98M
Tango Therapeutics66.50M
Revenue Rankings